241 related articles for article (PubMed ID: 15552412)
1. Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer.
Carlson DJ; Stewart RD; Li XA; Jennings K; Wang JZ; Guerrero M
Phys Med Biol; 2004 Oct; 49(19):4477-91. PubMed ID: 15552412
[TBL] [Abstract][Full Text] [Related]
2. How low is the alpha/beta ratio for prostate cancer?
Wang JZ; Guerrero M; Li XA
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):194-203. PubMed ID: 12504054
[TBL] [Abstract][Full Text] [Related]
3. In vitro determination of radiation sensitivity parameters for DU-145 prostate cancer cells.
Wang JZ; Rhee JG; Shi P; Stewart RD; Allen Li X
Int J Radiat Biol; 2008 Jun; 84(6):515-22. PubMed ID: 18470750
[TBL] [Abstract][Full Text] [Related]
4. Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters.
Carlson DJ; Stewart RD; Semenenko VA
Med Phys; 2006 Sep; 33(9):3105-15. PubMed ID: 17022202
[TBL] [Abstract][Full Text] [Related]
5. The low alpha/beta ratio for prostate cancer: what does the clinical outcome of HDR brachytherapy tell us?
Wang JZ; Li XA; Yu CX; DiBiase SJ
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1101-8. PubMed ID: 14575842
[TBL] [Abstract][Full Text] [Related]
6. Radiosensitivity of Prostate Cancer Cell Lines for Irradiation from Beta Particle-emitting Radionuclide ¹⁷⁷Lu Compared to Alpha Particles and Gamma Rays.
Elgqvist J; Timmermand OV; Larsson E; Strand SE
Anticancer Res; 2016 Jan; 36(1):103-9. PubMed ID: 26722033
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy.
Pop LA; Millar WT; Visser AG; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):215-26. PubMed ID: 11516872
[TBL] [Abstract][Full Text] [Related]
8. Effect of heterogeneity in radiosensitivity on LQ based isoeffect formalism for low alpha/beta cancers.
Moiseenko V
Acta Oncol; 2004; 43(5):499-502. PubMed ID: 15360056
[TBL] [Abstract][Full Text] [Related]
9. Impact of prolonged fraction delivery times on tumor control: a note of caution for intensity-modulated radiation therapy (IMRT).
Wang JZ; Li XA; D'Souza WD; Stewart RD
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):543-52. PubMed ID: 12957268
[TBL] [Abstract][Full Text] [Related]
10. Dose fractionation effects in primary and metastatic human uveal melanoma cell lines.
van den Aardweg GJ; Kiliç E; de Klein A; Luyten GP
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4660-4. PubMed ID: 14578382
[TBL] [Abstract][Full Text] [Related]
11. Radiobiological studies of PC-3 and DU-145 human prostate cancer cells: x-ray sensitivity in vitro and hypoxic fractions of xenografted tumors in vivo.
Leith JT; Quaranto L; Padfield G; Michelson S; Hercbergs A
Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):283-7. PubMed ID: 8420876
[TBL] [Abstract][Full Text] [Related]
12. Is alpha/beta for prostate tumors really low?
Fowler J; Chappell R; Ritter M
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1021-31. PubMed ID: 11429230
[TBL] [Abstract][Full Text] [Related]
13. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning.
Guerrero M; Li XA
Phys Med Biol; 2003 Oct; 48(20):3307-26. PubMed ID: 14620060
[TBL] [Abstract][Full Text] [Related]
14. Effect of patient variation on standard- and hypo-fractionated radiotherapy of prostate cancer.
Xiong W; Li J; Ma CM
Phys Med Biol; 2005 Apr; 50(7):1483-92. PubMed ID: 15798338
[TBL] [Abstract][Full Text] [Related]
15. What hypofractionated protocols should be tested for prostate cancer?
Fowler JF; Ritter MA; Chappell RJ; Brenner DJ
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1093-104. PubMed ID: 12829147
[TBL] [Abstract][Full Text] [Related]
16. TCP isoeffect analysis using a heterogeneous distribution of radiosensitivity.
Carlone M; Wilkins D; Nyiri B; Raaphorst P
Med Phys; 2004 May; 31(5):1176-82. PubMed ID: 15191307
[TBL] [Abstract][Full Text] [Related]
17. The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate.
Sminia P; Schneider CJ; Fowler JF
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):844-9. PubMed ID: 11849810
[TBL] [Abstract][Full Text] [Related]
18. Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio.
Nahum AE; Movsas B; Horwitz EM; Stobbe CC; Chapman JD
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):391-401. PubMed ID: 12957250
[TBL] [Abstract][Full Text] [Related]
19. In vitro radiation sensitivity of the LNCaP prostatic tumor cell line.
Leith JT
Prostate; 1994; 24(3):119-24. PubMed ID: 8115277
[TBL] [Abstract][Full Text] [Related]
20. Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models.
King CR; DiPetrillo TA; Wazer DE
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):165-72. PubMed ID: 10656389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]